Tag archive for ‘inflammatory diseases’
Jewish Business News On Tuesday, February 17th, 2015

Can-Fite Receives Notice of Allowance in US for Psoriasis Patent

Israel’s Can-Fite BioPharma Ltd., a biotechnology company which develops proprietary small molecule drugs for treating cancer and inflammatory diseases, announced that it has received a Notice of Allowance More...

Can-Fite is part of Israel startup nation

Can-Fite’s new Drug Fights Diabetes-Related Erectile Dysfunction

Israel’s Can-Fite BioPharma Ltd., a biotechnology company which develops proprietary small molecule drugs for treating cancer and inflammatory diseases, reported it has received positive data regarding More...

Gil Tanenbaum On Tuesday, December 30th, 2014

Israel’s Can-Fite BioPharma Moves Forward with Rheumatoid Arthritis Drug

Israel’s Can-Fite BioPharma Ltd., a biotechnology company which develops proprietary small molecule drugs for treating cancer and inflammatory diseases, has completed the Design of the Rheumatoid Arthritis More...

Gil Tanenbaum On Monday, December 22nd, 2014

Can-Fite Treats First Patient with New Cancer Drug

Israel’s Can-Fite BioPharma Ltd., a biotechnology company which develops proprietary small molecule drugs for treating cancer and inflammatory diseases, treated the first patient with its CF 102 in a Phase More...

RedHill Biopharma Acquires Technology from University of Minnesota

– The University of Minnesota is buying rights for the development of a diagnostic Crohn’s disease test. Israeli RedHill Biopharma Ltd. (Nasdaq:RDHL) (TASE:RDHL) , has entered into a license agreement More...

Gil Tanenbaum On Thursday, November 20th, 2014

Israel’s Immune Pharmaceuticals to Issue New Stock

Israel’s Immune Pharmaceuticals Inc., a clinical stage biopharmaceutical company that engages in the development and commercialization of targeted therapeutics for the treatment of inflammatory diseases More...

Can-Fite is part of Israel startup nation
Gil Tanenbaum On Wednesday, October 1st, 2014

Can-Fite BioPharma Liver Drug Gets US Patent

Israel’s Can-Fite BioPharma Ltd., a biotechnology company advancing a pipeline of proprietary small molecule drugs that address cancer and inflammatory diseases, has received a patent in the US for its More...

Jewish Business News On Monday, June 30th, 2014

RedHill Biopharma acquires Phase II oncology drug

– Mesupron,  which targets gastrointestinal and other cancers, has been licensed from Wilex. RedHill Biopharma Ltd. (Nasdaq: RDHL); TASE: RDHL) has expanded its late clinical-stage gastrointestinal-focused More...

Gali Weinreb On Monday, June 9th, 2014

VBL Therapeutics files for $75 million Nasdaq IPO

– VBL is developing drugs for the treatment of cancer and inflammatory diseases. On Friday,  VBL Therapeutics Ltd. (formerly Vascular Biogenics) published a draft prospectus with the US Securities More...

Wordpress site Developed by Fixing WordPress Problems